Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2000 | 04-1999 | 04-1998 | 04-1997 | 04-1996 | |
| Sales | 2,217 | 2,190 | 2,320 | 2,160 | 2,130 |
| Cost of Goods | 1,787 | 1,760 | 600 | 528 | 512 |
| Gross Profit | 430 | 430 | 1,720 | 1,612 | 1,594 |
| Operating Expenses | 1,166 | 1,160 | 2,240 | 578 | 572 |
| Operating Income | 52 | 30 | 80 | 1,582 | 1,558 |
| Interest Expense | 4 | 5 | 1 | 3 | 5 |
| Other Income | 4 | -15 | 281 | -1,519 | -1,513 |
| Pre-tax Income | 52 | 10 | 360 | 60 | 40 |
| Income Tax | N/A | 0 | 8 | -210 | N/A |
| Net Income Continuous | 52 | 16 | 64 | 283 | 49 |
| Net Income Discontinuous | N/A | 0 | 0 | -216 | 0 |
| Net Income | $52 | $10 | $350 | $280 | $40 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.36 | 0.36 | 0.12 |
| EPS Basic Continuous Ops | 0.07 | 0.02 | 0.09 | 0.42 | 0.12 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.32 | N/A |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.36 | 0.36 | 0.12 |
| EPS Diluted Continuous Ops | 0.07 | 0.02 | 0.09 | 0.42 | 0.12 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.32 | N/A |
| EBITDA(a) | $108 | $90 | $130 | $1,582 | $1,558 |